PRDX2 and Sjogren syndrome: With further analysis, the levels of S100A8 and S100A9 were found to be upregulated in Sjögren’s syndrome patients with DED, whereas the levels of lactoferrin and peroxiredoxin 2 (Prx2) decreased [22].